These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1700161)

  • 1. Comparison of a polyclonal and monoclonal immunoassay for PSA: need for an international antigen standard.
    Graves HC; Wehner N; Stamey TA
    J Urol; 1990 Dec; 144(6):1516-22. PubMed ID: 1700161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identity of prostate specific antigen and the semen protein P30 purified by a rapid chromatography technique.
    Graves HC; Kamarei M; Stamey TA
    J Urol; 1990 Dec; 144(6):1510-5. PubMed ID: 1700160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Basic and clinical evaluation of the new kit for detection of serum prostate specific antigen (PSA)].
    Akiyama A; Tochimoto M; Ito T; Tsujino S; Aizawa T; Namiki K; Miki M
    Kaku Igaku; 1992 Sep; 29(9):1151-8. PubMed ID: 1280697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of prostate-specific antigen in serum by immunoradiometric assay.
    Lindstedt G; Jacobsson A; Lundberg PA; Hedelin H; Pettersson S; Unsgaard B
    Clin Chem; 1990 Jan; 36(1):53-8. PubMed ID: 1688745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analytical performance of the Tandem-R free PSA immunoassay measuring free prostate-specific antigen.
    Woodrum DL; French CM; Hill TM; Roman SJ; Slatore HL; Shaffer JL; York LG; Eure KL; Loveland KG; Gasior GH; Southwick PC; Shamel LB
    Clin Chem; 1997 Jul; 43(7):1203-8. PubMed ID: 9216457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostate-specific antigen as a marker for prostatic cancer: a monoclonal and a polyclonal immunoassay compared.
    Chan DW; Bruzek DJ; Oesterling JE; Rock RC; Walsh PC
    Clin Chem; 1987 Oct; 33(10):1916-20. PubMed ID: 2444361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-reactivity of monomeric and dimeric biosynthetic human growth hormone in commercial immunoassays.
    Bowsher RR; Apathy JM; Ferguson AL; Riggin RM; Henry DP
    Clin Chem; 1990 Feb; 36(2):362-6. PubMed ID: 2302782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparative assessment of the characteristics in various assay kits for prostate specific antigen].
    Akiyama A; Yamamoto S; Hokoishi F; Ogawa M; Aizawa T; Matsumoto T; Miki M
    Nihon Hinyokika Gakkai Zasshi; 1993 Dec; 84(12):2103-8. PubMed ID: 7508530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparison of 3 assay kits of prostate specific antigen in serum of prostatic cancer].
    Akimoto S; Akakura K; Shimazaki J
    Hinyokika Kiyo; 1988 Dec; 34(12):2143-8. PubMed ID: 2467543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Standardization with synthetic 22-kDa monomer human growth hormone reduces discrepancies between two monoclonal immunoradiometric assay kits.
    Banfi G; Marinelli M; Pontillo M; Bonini P
    Clin Chem; 1992 Oct; 38(10):2107-10. PubMed ID: 1395000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in values obtained with 2 assays of prostate specific antigen.
    Hortin GL; Bahnson RR; Daft M; Chan KM; Catalona WJ; Ladenson JH
    J Urol; 1988 Apr; 139(4):762-5. PubMed ID: 2451036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultrasensitive radioimmunoassay of prostate-specific antigen.
    Graves HC; Wehner N; Stamey TA
    Clin Chem; 1992 May; 38(5):735-42. PubMed ID: 1374691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measurement of prostate-specific antigen in serum using four different immunoassays.
    Cattini R; Robinson D; Gill O; Jolley N; Bacarese-Hamilton T
    Eur J Clin Chem Clin Biochem; 1994 Mar; 32(3):181-5. PubMed ID: 7518258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparison of Tandem-R PSA and Markit-M PA in the diagnosis of prostate cancer].
    Okegawa T; Kato M; Miyata A; Murata A; Miura I; Yoneda T; Nutahara K; Higashihara E
    Hinyokika Kiyo; 1999 Mar; 45(3):175-8. PubMed ID: 10331169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum thyrotropin as measured with a one-step monoclonal-antibody radioimmunometric assay compared with two commercial radioimmunoassay kits.
    Pekary AE; Hershman JM
    Clin Chem; 1986 Jun; 32(6):1007-9. PubMed ID: 3708800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Studies of prostate-specific antigen (PSA) immunoassays--differences in characteristic of immunoreactivity and reference materials among the kits].
    Umeda H; Sumi S; Honda M; Hosoya Y; Arai K; Yano M; Koga F; Nakajima K; Nakanishi K; Maeda S; Kitahara S; Yoshida K
    Nihon Hinyokika Gakkai Zasshi; 1998 Mar; 89(3):426-33. PubMed ID: 9577558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of a cytokeratin 19 assay kit "BALL ELSA CYFRA21-1"].
    Sakahara H; Kousaka T; Hattori N; Hosono M; Kobayashi H; Shirato M; Yao Z; Konishi J
    Kaku Igaku; 1993 Dec; 30(12):1475-9. PubMed ID: 7509008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of common matrices for assay standards on performance of 'ultra sensitive' immunometric assays for TSH. Report of a joint WHO/IFCC collaborative study.
    Gaines-Das RE; Brettschneider H; Bristow AF
    Clin Chim Acta; 1991 Dec; 203(2-3):S5-15. PubMed ID: 1777974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate specific antigen in patients with clinical stage C prostate cancer: relation to lymph node status and grade.
    Greskovich FJ; Johnson DE; Tenney DM; Stephenson RA
    J Urol; 1991 Apr; 145(4):798-801. PubMed ID: 1706439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of serum concentrations of PSA-ACT complex with total PSA in random and serial specimens from patients with BPH and prostate cancer.
    Wu JT; Wilson L; Zhang P; Meikle AW; Stephenson R
    J Clin Lab Anal; 1995; 9(1):15-24. PubMed ID: 7536835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.